SARS-CoV-2, COVID-19 and the aging immune system

JM Bartleson, D Radenkovic, AJ Covarrubias… - Nature aging, 2021 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a global health threat with
particular risk for severe disease and death in older adults and in adults with age-related …

COVID-19 vaccines: The status and perspectives in delivery points of view

JY Chung, MN Thone, YJ Kwon - Advanced drug delivery reviews, 2021 - Elsevier
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …

A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19

B Thakur, P Dubey, J Benitez, JP Torres, S Reddy… - Scientific reports, 2021 - nature.com
Several comorbidities have been shown to be associated with coronavirus disease 2019
(COVID-19) related severity and mortality. However, considerable variation in the …

Racial disparities in incidence and outcomes among patients with COVID-19

LS Muñoz-Price, AB Nattinger, F Rivera… - JAMA network …, 2020 - jamanetwork.com
Importance Initial public health data show that Black race may be a risk factor for worse
outcomes of coronavirus disease 2019 (COVID-19). Objective To characterize the …

Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review

C Eberle, S Stichling - Diabetology & metabolic syndrome, 2021 - Springer
Background In 2019, a new virus known as severe acute respiratory syndrome coronavirus
type 2 (SARS-CoV-2) has emerged. Coronavirus disease 2019 (COVID-19) was classified …

HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry

C Wei, L Wan, Q Yan, X Wang, J Zhang, X Yang… - Nature …, 2020 - nature.com
Responsible for the ongoing coronavirus disease 19 (COVID-19) pandemic, severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells through binding of the …

Temporal changes in factors associated with COVID-19 vaccine hesitancy and uptake among adults in Hong Kong: Serial cross-sectional surveys

J Xiao, JK Cheung, P Wu, MY Ni… - The Lancet Regional …, 2022 - thelancet.com
Background COVID-19 vaccine hesitancy can lead to reduced vaccine uptake and hinder
the safe relaxation of other public health measures. This study aims to explore the factors …

The effects of the health system response to the COVID-19 pandemic on chronic disease management: a narrative review

T Kendzerska, DT Zhu, AS Gershon… - … and healthcare policy, 2021 - Taylor & Francis
Background Individuals with chronic conditions require ongoing disease management to
reduce risks of adverse health outcomes. During the COVID-19 pandemic, health care for …

COVID–19 and chronic kidney disease: an updated overview of reviews

SS Jdiaa, R Mansour, A El Alayli, A Gautam… - Journal of …, 2022 - Springer
Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …

Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge

MM Maestre-Muñiz, Á Arias, E Mata-Vázquez… - Journal of clinical …, 2021 - mdpi.com
Background: The long-term effects of COVID-19 remain largely unclear. This study aims to
investigate post-acute health consequences and mortality one year after hospital discharge …